Court Opinion

ID: 4317397
Source: CourtListenerOpinion
Date Created: 2018-10-02 15:03:22.1819+00
Date Added: 2024-06-11T13:55:41.646827
License: Public Domain

NOTE: This order is nonprecedential.

  United States Court of Appeals
      for the Federal Circuit
                 ______________________

       ALTAIRE PHARMACEUTICALS, INC.,
                  Appellant

                            v.

              PARAGON BIOTECK, INC.,
                       Appellee
                ______________________

                       2017-1487
                 ______________________

    Appeal from the United States Patent and Trademark
Office, Patent Trial and Appeal Board in No. PGR2015-
00011.
                 ______________________

Before O’MALLEY, SCHALL, and WALLACH, Circuit Judges.
PER CURIAM.
                       ORDER
    Upon consideration of the parties’ September 24, 2018
response to this court’s order to show cause,
   IT IS ORDERED THAT:
    We do not typically vacate an issued opinion. Cf. Tivo
Inc. v. EchoStar Corp., 429 F. App’x 975, 976 (Fed. Cir.
2011). However, in light of the parties’ settlement in this
case, the court shall modify the precedential opinion and
2             ALTAIRE PHARM., INC.   v. PARAGON BIOTECK, INC.

judgment issued May 2, 2018, by vacating only the por-
tion that orders remand to the U.S. Patent and Trade-
mark Office’s Patent Trial and Appeal Board. Any
citation to our underlying opinion should read: Altaire
Pharmaceuticals, Inc. v. Paragon Bioteck, Inc., 889 F.3d
1274 (Fed. Cir. 2018), remand order modified by stipula-
tion, [this order].

                               FOR THE COURT

October 2, 2018                 /s/ Peter R. Marksteiner
      Date                      Peter R. Marksteiner
                                Clerk of Court